Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
08:00am, Tuesday, 23'rd Jan 2024
Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and Profitability Company in Late-Stage Discussions with Two Additional Large Global Brands
ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript
04:11pm, Thursday, 09'th Nov 2023
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2023 Earnings Conference Call November 9, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Pa
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time
08:00am, Thursday, 02'nd Nov 2023
GARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursd
Pharmaloz plan is to build capacity with a goal to attain a revenue run-rate of $60 to $80 million by year-end 2024, with 20-25% pre-tax net margins and a goal for additional growth thereafter.
ProPhase Labs to Present at The ThinkEquity Conference
08:00am, Thursday, 12'th Oct 2023
GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be participati
ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript
11:04am, Saturday, 12'th Aug 2023
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Par
ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates
10:46am, Thursday, 10'th Aug 2023
ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.40 per share a year ago.
Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 20
ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time
08:00am, Wednesday, 02'nd Aug 2023
GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursd
Navidea Biopharmaceuticals rejects ProPhase Labs offer
09:44am, Friday, 30'th Jun 2023
Navidea Biopharmaceuticals Inc. NAVB, -2.38% announced Friday that it had rejected an unsolicited ProPhase Labs Inc. PRPH, +0.08% offer for certain Navidea assets, saying the proposal undervalues Navi
ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy
01:16am, Sunday, 11'th Jun 2023
ProPhase Labs thrived in the Covid era and then wisely used the gains to invest in new testing capabilities including whole genome sequencing and a new esophageal cancer test. The capabilities will al
ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023
08:00am, Wednesday, 07'th Jun 2023
Garden City, NY, June 07, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that management wil
ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?
05:20am, Wednesday, 03'rd May 2023
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
7 Small-Cap Biotech Stocks with Massive Potential
06:36pm, Thursday, 27'th Apr 2023
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappo
ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock?
04:35am, Monday, 10'th Apr 2023
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near t
